← All trials
NCT05234190
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 21, 2022
- Primary completion
- Jun 30, 2025
- Completion date
- Mar 31, 2039
- First posted
- Feb 10, 2022
- Last posted
- Dec 26, 2022
- Enrollment
- 33
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Quell Therapeutics LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.